Found 5 clinical trials
COVID-19 Booster Vaccine in Autoimmune Disease Non-Responders
>Juvenile Dermatomyositis (JDM)
- 79 views
- 07 Apr, 2023
- 23 locations
Transition to Adulthood Through Coaching and Empowerment in Rheumatology (TRACER)
TRACER is a study aiming to investigate the feasibility of transition coaching sessions for patients moving from paediatric to adult rheumatology care.
- 0 views
- 10 Apr, 2023
- 2 locations
An Open-label Study of Sodium Thiosulfate for Treatment of Calcinosis Associated With Juvenile and Adult Dermatomyositis
Background Dermatomyositis (DM) and juvenile dermatomyositis (JDM) cause inflammation in the muscles. People with DM and JDM can develop calcium deposits in places
- 190 views
- 22 Oct, 2022
- 1 location
Studies of the Natural History, Pathogenesis, and Outcome of Autoinflammatory Diseases Including Juvenile Dermatomyositis
Purpose The purpose of this protocol is 1. To comprehensively evaluate patients with autoinflammatory diseases clinically, genetically and immunologically at the autoinflammatory disease clinic at the NIH. 2. To follow patients with autoinflammatory Diseases that are genetically defined including Neonatal-Onset Multisystem Inflammatory Disease (NOMID), the most severe clinical phenotype of …
- 537 views
- 12 Apr, 2023
- 1 location
Environmental Risk Factors for the Anti-Synthetase Syndrome
Background Like other complex diseases, autoimmune diseases are the result of numerous causes, including genetic and environmental factors. Some researchers believe that people who are susceptible to autoimmune disorders develop them when the body reacts to environmental or other factors by creating white blood cells that attack the body s …
- 142 views
- 24 Oct, 2022
- 2 locations